Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc.verified

KPRX

Price:

$4.23

Market Cap:

$12.57M

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patient...[Read more]

Industry

Biotechnology

IPO Date

2015-02-13

Stock Exchange

NASDAQ

Ticker

KPRX

The ROE as of July 2024 (TTM) for Kiora Pharmaceuticals, Inc. (KPRX) is 17.90%

According to Kiora Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 17.90%. This represents a change of -180.56% compared to the average of -22.22% of the last 4 quarters.

Kiora Pharmaceuticals, Inc. (KPRX) Historical ROE (quarterly & annually)

How has KPRX ROE performed in the past?

The mean historical ROE of Kiora Pharmaceuticals, Inc. over the last ten years is 375.71%. The current 17.90% ROE has changed -95.24% with respect to the historical average. Over the past ten years (40 quarters), KPRX's ROE was at its highest in in the December 2016 quarter at 1.12%. The ROE was at its lowest in in the September 2017 quarter at -609.38%.

Quarterly (TTM)
Annual

Average

375.71%

Median

-117.34%

Minimum

-204.82%

Maximum

4.05%

Kiora Pharmaceuticals, Inc. (KPRX) ROE by Quarter and Year

Discovering the peaks and valleys of Kiora Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 72.01%

Maximum Annual ROE = 4.05%

Minimum Annual Increase = -3738.28%

Minimum Annual ROE = -204.82%

Quarterly (TTM)
Annual
YearROEChange
2023-204.82%72.01%
2022-119.08%-33.00%
2021-177.73%53.74%
2020-115.61%7.88%
2019-107.16%-11.43%
2018-120.98%-117.64%
2017685.96%-83.07%
20164.05%-3037.50%
2015-137.89%-3738.28%
20143.79%-56.19%

Kiora Pharmaceuticals, Inc. (KPRX) Average ROE

How has KPRX ROE performed in the past?

The current ROE of Kiora Pharmaceuticals, Inc. (KPRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-167.21%

5-year avg

-144.88%

10-year avg

375.71%

Kiora Pharmaceuticals, Inc. (KPRX) ROE vs. Peers

How is KPRX’s ROE compared to its peers?

Kiora Pharmaceuticals, Inc.’s ROE is greater than Virax Biolabs Group Limited (-89.57%), greater than Blue Water Vaccines, Inc. (-111.44%), greater than Revelation Biosciences, Inc. (-98.60%), greater than Hillstream BioPharma, Inc. (-47249.59%), greater than Quoin Pharmaceuticals, Ltd. (-108.19%), less than Allarity Therapeutics, Inc. (405.19%), less than Kiromic BioPharma, Inc. (321.55%), greater than Biodexa Pharmaceuticals Plc (-141.90%), less than Unicycive Therapeutics, Inc. (822.27%), greater than Cardio Diagnostics Holdings, Inc. (-411.32%), greater than PaxMedica, Inc. Common Stock (-1151.68%), less than Panbela Therapeutics, Inc. (1.96%), greater than Palisade Bio, Inc. (-105.25%),

Build a custom stock screener for Kiora Pharmaceuticals, Inc. (KPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiora Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kiora Pharmaceuticals, Inc. (KPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kiora Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Kiora Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the highest ROE for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the 3-year average ROE for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the 5-year average ROE for Kiora Pharmaceuticals, Inc. (KPRX)?

How does the current ROE for Kiora Pharmaceuticals, Inc. (KPRX) compare to its historical average?